Kura Oncology, Inc. (NASDAQ: KURA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT KURA ONCOLOGY, INC.

Kura Oncology, Inc. (NASDAQ: KURA)
Listen to this Section


$8.87
+0.0970 ( +1.11% ) 1.3M

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

Market Data


Open $8.87
Previous Close $8.77
Volume 1.3M
Market Cap $778.55M
Day Range $8.55 - $9.20
52 Week Range $5.45 - $12.49
Shares Outstanding 88.77M
Change % +1.11%
Net Change ▲ 0.0970
Insider Ownership -0.04%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2015
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -20,109.00

Date Type Amount Purchased Purchaser
2025-09-09 Buy 50000.00 WILSON TROY EDWARD
2025-08-14 Buy 36506.00 WILSON TROY EDWARD
2024-06-07 Sale -26000.00 Collins Helen Louise
2024-06-07 Sale -26000.00 Parks Diane L.
2024-06-07 Sale -26000.00 Szela Mary T
2024-06-07 Sale -26000.00 Hasnain Faheem
2024-05-20 Sale -2615.00 Bair Teresa Brophy

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
8-k 8K-related 11 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
8-k 8K-related 43 Jun 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy